Changing the Future of Drug Delivery
Lindy is seeking to improve patient comfort, convenience, and cost by revolutionizing the field of drug delivery. Explore the latest news and events from Lindy Biosciences.
Lindy Biosciences Selects Lifecore Biomedical to Support Process Development and Commercial Scale-Up
OCTOBER 2024, RALEIGH, NC
Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organization (CDMO) was selected to scale up Lindy Biosciences' innovative microglassification technology for commercial manufacturing. Learn more.
Lindy Biosciences Enters Licensing And Collaboration Agreement With Novartis For Multi-Target Drug Delivery Innovation
AUGUST 2024, RALEIGH, NC
Lindy Biosciences partners with Novartis in a $954 million collaboration to advance self-administered drug treatments using proprietary microglassification technology. Learn more.
Lindy Biosciences Founder and CEO to Present at the Controlled Release Society Annual Meeting in Bologna, Italy
JULY 2024, MORRISVILLE, NC
Our CEO and Founder Deborah Bitterfield, PhD, is thrilled to attend and speak at Technical Session VII during #CRS2024!
Lindy Biosciences to Present at Upcoming CED Venture Connect Investor Conference
MARCH 2023, RESEARCH TRIANGLE PARK, NC
Lindy Biosciences has been selected to present at the upcoming 39th annual CED Venture Connect Investor Conference, one of the largest of its kind in the Southeast. Deborah Bitterfield (CEO) will present on Thursday March 30, 2023 during the drug delivery session.
OCTOBER 2022, BOSTON, MA
Lindy Biosciences CEO Deborah Bitterfield to participate in an expert panel at the 12th annual PODD conference.
AUGUST 2022, BOSTON, MA
BOSTON, MA – Lindy Biosciences CEO Deborah Bitterfield speaks in session titled “Redefining High-Concentration Formulations: Beyond the Aqueous Limit”.
JULY 2022, RESEARCH TRIANGLE PARK, NC
Lindy Biosciences, a Research Triangle Park-based biotechnology company, has raised more than $4.25 million, according to an SEC filing.
MAY 2022, RESEARCH TRIANGLE PARK, NC
In this session titled "Partner or Peril", Deborah joined a panel of boardroom experts who have built strong partner networks focused on finding the right partners and the implications of long-term partnerships aimed for success.
APRIL 2022, RESEARCH TRIANGLE PARK, NC
Deborah Bitterfield (CEO, Lindy Biosciences) presents at CED’s Venture Connect 2022 Summit. Lindy Biosciences is invited and featured for an on-stage presentation showcasing our platform drug delivery technology with Angel and VC investors, corporate partners, and the life science community.
Lindy Biosciences exhibitor at NCBIO’s “Academic Engagement Night”
MARCH 2022, RESEARCH TRIANGLE PARK, NC
An academic engagement event designed for college students to learn more about the life sciences industry. LEARN MORE HERE